As Medicare Broadens Coverage Of Alzheimer’s Disease Drug Leqembi, Details Emerge Regarding What Access Entails

As CMS expands coverage of Leqembi it’s unclear how patient registries will work, how comprehensive scan coverage will be, and whether local carriers have any discretion.

Read the full post on Forbes - Healthcare